SLC39A5 and metabolic dysfunction-associated steatohepatitis: Nonetheless, given the connection with protective effects arising from heterozygous loss of SLC39A5 in humans, we examined the effect of loss of Slc39a5 in mice under conditions of metabolic stress, employing models of congenital or diet-induced obesity, and NASH.